KR100967152B1 - 신규한 펩티드 및 이의 의약적 용도 - Google Patents
신규한 펩티드 및 이의 의약적 용도 Download PDFInfo
- Publication number
- KR100967152B1 KR100967152B1 KR1020047008365A KR20047008365A KR100967152B1 KR 100967152 B1 KR100967152 B1 KR 100967152B1 KR 1020047008365 A KR1020047008365 A KR 1020047008365A KR 20047008365 A KR20047008365 A KR 20047008365A KR 100967152 B1 KR100967152 B1 KR 100967152B1
- Authority
- KR
- South Korea
- Prior art keywords
- ser
- peptide
- amino acid
- arg
- acid sequence
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
Abstract
Description
피험 약물 | 신전율(%) |
대조군 | 100 |
SSSR (1nM) GSSSR (1nM) SSSRR (1nM) GSSSRR (1nM) GSSSRRAP (1nM) GSSSRAAAP (1nM) GYGSSSRRAPQT (1nM) 물질 P (20 μM) FGLM (20 μM) |
101 101 98 94 97 100 104 94 99 |
SSSR (1 nM) + 물질 P (20 μM) GSSSR (1nM) + 물질 P (20 μM) SSSRR (1nM) + 물질 P (20 μM) GSSSRR (1nM) + 물질 P (20 μM) GSSSRRAP (1nM) + 물질 P (20 μM) ASSSRRAP (1nM) + 물질 P (20 μM) GSSSRAAP (1nM) + 물질 P (20 μM) GSSSRAAAP (1nM) + 물질 P (20 μM) GYGSSSRRAPQT (1nM) + 물질 P (20 μM) SSSR (1nM) + FGLM (20 μM) |
138 135 136 142 140 134 150 139 134 145 |
Claims (14)
- 아미노산 배열이 Ser-Ser-Ser-Arg인 펩티드 또는 이의 의약으로서 허용되는 염류.
- 아미노산 배열이 Ser-Ser-Ser-Arg인 펩티드 또는 이의 의약으로서 허용되는 염류를 필수 성분으로서 포함하고, 의약으로서 허용되는 첨가물을 배합하여 이루어지는 각막 장해 치료제 또는 피부 창상 치유 촉진제.
- 1) 아미노산 배열이 Ser-Ser-Ser-Arg인 펩티드 또는 이의 의약으로서 허용되는 염류, 및2) 아미노산 배열이 Phe-Gly-Leu-Met-NH2인 펩티드 또는 물질 P 또는 이들의 의약으로서 허용되는 염류를 포함하는 각막 장해 치료제.
- 제2항 또는 제3항에 있어서, 각막 장해가 각막 궤양, 각막 상피 박리, 각막염 또는 안구건조증인 각막 장해 치료제.
- 제4항에 있어서, 제형이 점안제인 각막 장해 치료제.
- 1) 아미노산 배열이 Ser-Ser-Ser-Arg인 펩티드 또는 이의 의약으로서 허용되는 염류, 및2) 아미노산 배열이 Phe-Gly-Leu-Met-NH2인 펩티드 또는 물질 P 또는 이들의 의약으로서 허용되는 염류를 포함하는 피부 창상 치유 촉진제.
- 제6항에 있어서, 피부 창상이 열상, 찰과상, 외과적 절개, 피부 궤양 또는 화상인 피부 창상 치유 촉진제.
- 제7항에 있어서, 제형이 연고제 또는 첩부제인 피부 창상 치유 촉진제.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2001-00368103 | 2001-12-03 | ||
JP2001368103 | 2001-12-03 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097024352A Division KR100993233B1 (ko) | 2001-12-03 | 2002-12-03 | 신규한 펩티드 및 이의 의약적 용도 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050044630A KR20050044630A (ko) | 2005-05-12 |
KR100967152B1 true KR100967152B1 (ko) | 2010-07-05 |
Family
ID=19177744
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097024352A KR100993233B1 (ko) | 2001-12-03 | 2002-12-03 | 신규한 펩티드 및 이의 의약적 용도 |
KR1020047008365A KR100967152B1 (ko) | 2001-12-03 | 2002-12-03 | 신규한 펩티드 및 이의 의약적 용도 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097024352A KR100993233B1 (ko) | 2001-12-03 | 2002-12-03 | 신규한 펩티드 및 이의 의약적 용도 |
Country Status (13)
Country | Link |
---|---|
US (3) | US7232881B2 (ko) |
EP (2) | EP2172474B1 (ko) |
JP (1) | JP4310588B2 (ko) |
KR (2) | KR100993233B1 (ko) |
CN (1) | CN1263770C (ko) |
CA (1) | CA2469134C (ko) |
CY (1) | CY1114330T1 (ko) |
DK (1) | DK1462455T3 (ko) |
ES (1) | ES2422081T3 (ko) |
PT (1) | PT1462455E (ko) |
SI (1) | SI1462455T1 (ko) |
TW (1) | TWI305778B (ko) |
WO (1) | WO2003048192A1 (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006143601A (ja) * | 2004-11-16 | 2006-06-08 | Yamato Yakuhin Kk | 血液粘度低下剤 |
WO2007102686A1 (en) | 2006-03-06 | 2007-09-13 | Caregen Co., Ltd | Peptides having activities of insulin like growth factor-1 and their uses |
WO2008086358A1 (en) | 2007-01-08 | 2008-07-17 | University Of Southern California Usc Stevens | Skin wound healing compositions and methods of use thereof |
SI2247620T1 (sl) | 2008-01-31 | 2016-09-30 | Genentech, Inc. | Protitelesa proti CD79b in imunokonjugati in postopki za uporabo |
KR101021197B1 (ko) | 2008-04-11 | 2011-03-11 | (주)케어젠 | 성장인자―미미킹 펩타이드 및 그의 용도 |
KR101163171B1 (ko) | 2009-01-20 | 2012-07-19 | (주)케어젠 | 노긴?유래 펩타이드 및 그의 용도 |
US8207118B2 (en) * | 2009-07-17 | 2012-06-26 | University Of Southern California | Skin wound healing compositions and methods of use thereof |
CA2772220A1 (en) * | 2009-09-25 | 2011-03-31 | Santen Pharmaceutical Co. Ltd. | Eye drops |
CN102612373B (zh) * | 2009-11-11 | 2016-03-02 | 国立大学法人山口大学 | 消化器官疾病治疗剂 |
DK2635293T3 (en) * | 2010-11-03 | 2018-06-14 | Univ Southern California | Skin ulcer preparations and methods for their use |
EP3262060B1 (en) * | 2015-02-25 | 2019-12-25 | MacKay Memorial Hospital | Peptides for use in the prevention and treatment of dry eye |
CN108290056B (zh) * | 2015-12-14 | 2021-09-14 | 曹友平 | 短合成肽及其用途 |
KR101869783B1 (ko) * | 2016-08-17 | 2018-06-22 | (주)진셀팜 | 미백 활성이 우수한 펩타이드, 및 이의 용도 |
US10467113B2 (en) * | 2017-06-09 | 2019-11-05 | Hewlett Packard Enterprise Development Lp | Executing programs through a shared NVM pool |
CN112043818A (zh) * | 2020-09-16 | 2020-12-08 | 温州医科大学附属第一医院 | 一种用于皮肤创伤的药物及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6417489A (en) * | 1987-07-13 | 1989-01-20 | Hitachi Ltd | Extended substrate |
WO1993023067A1 (en) * | 1992-05-08 | 1993-11-25 | Thomas Jefferson University | Igf-1 analogs |
US5703045A (en) | 1989-06-05 | 1997-12-30 | Cephalon, Inc. | Treating disorders by application of insulin-like growth factors and analogs |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4885163A (en) | 1987-02-24 | 1989-12-05 | Eli Lilly And Company | Topical use of IGF-II for wound healing |
NZ226171A (en) | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
US5093317A (en) * | 1989-06-05 | 1992-03-03 | Cephalon, Inc. | Treating disorders by application of insulin-like growth factor |
US5104787A (en) | 1990-03-05 | 1992-04-14 | Lindstrom Richard L | Method for apparatus for a defined serumfree medical solution useful for corneal preservation |
US5616562A (en) * | 1990-04-27 | 1997-04-01 | Murphy; Christopher J. | Methods and compositions using substance P to promote wound healing |
JPH0525001A (ja) | 1991-07-08 | 1993-02-02 | L Lyndstrom Richard | 血清不含有医療用溶液および眼組織の品質を高める方法 |
US6310040B1 (en) * | 1991-11-08 | 2001-10-30 | Cephalon, Inc. | Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
US5545617A (en) | 1993-11-12 | 1996-08-13 | The Schepens Eye Research Institute, Inc. | Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
JP3191038B2 (ja) * | 1996-06-26 | 2001-07-23 | 輝夫 西田 | 眼科用医薬組成物 |
EP1308165B1 (en) * | 2000-08-10 | 2010-06-09 | Santen Pharmaceutical Co., Ltd. | Skin wound healing promoters |
JP4096115B2 (ja) * | 2000-08-10 | 2008-06-04 | 輝夫 西田 | 皮膚創傷治癒促進剤 |
AUPR030900A0 (en) * | 2000-09-22 | 2000-10-12 | Queensland University Of Technology | Growth factor complex |
JP4253743B2 (ja) * | 2001-12-03 | 2009-04-15 | 輝夫 西田 | 新規ペプチドおよびその医薬用途 |
-
2002
- 2002-12-02 TW TW091134925A patent/TWI305778B/zh not_active IP Right Cessation
- 2002-12-03 SI SI200231028T patent/SI1462455T1/sl unknown
- 2002-12-03 EP EP10000425.8A patent/EP2172474B1/en not_active Expired - Lifetime
- 2002-12-03 KR KR1020097024352A patent/KR100993233B1/ko active IP Right Grant
- 2002-12-03 PT PT2786015T patent/PT1462455E/pt unknown
- 2002-12-03 CN CNB028241649A patent/CN1263770C/zh not_active Expired - Lifetime
- 2002-12-03 CA CA2469134A patent/CA2469134C/en not_active Expired - Fee Related
- 2002-12-03 WO PCT/JP2002/012632 patent/WO2003048192A1/ja active Application Filing
- 2002-12-03 EP EP02786015.4A patent/EP1462455B1/en not_active Expired - Lifetime
- 2002-12-03 KR KR1020047008365A patent/KR100967152B1/ko active IP Right Grant
- 2002-12-03 ES ES02786015T patent/ES2422081T3/es not_active Expired - Lifetime
- 2002-12-03 DK DK02786015.4T patent/DK1462455T3/da active
- 2002-12-03 US US10/497,628 patent/US7232881B2/en not_active Expired - Fee Related
-
2007
- 2007-03-20 US US11/725,761 patent/US7795222B2/en not_active Expired - Fee Related
-
2008
- 2008-03-17 JP JP2008067259A patent/JP4310588B2/ja not_active Expired - Lifetime
-
2010
- 2010-07-29 US US12/804,773 patent/US8183343B2/en not_active Expired - Fee Related
-
2013
- 2013-07-10 CY CY20131100584T patent/CY1114330T1/el unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6417489A (en) * | 1987-07-13 | 1989-01-20 | Hitachi Ltd | Extended substrate |
US5703045A (en) | 1989-06-05 | 1997-12-30 | Cephalon, Inc. | Treating disorders by application of insulin-like growth factors and analogs |
WO1993023067A1 (en) * | 1992-05-08 | 1993-11-25 | Thomas Jefferson University | Igf-1 analogs |
Non-Patent Citations (1)
Title |
---|
The Journal of Biological Chemistry, Vol.269(14), 1994, 10609-10613 |
Also Published As
Publication number | Publication date |
---|---|
DK1462455T3 (da) | 2013-07-01 |
CA2469134C (en) | 2013-10-29 |
ES2422081T3 (es) | 2013-09-06 |
EP1462455A4 (en) | 2008-12-31 |
CA2469134A1 (en) | 2003-06-12 |
US20110059897A1 (en) | 2011-03-10 |
US20050009752A1 (en) | 2005-01-13 |
TWI305778B (en) | 2009-02-01 |
JP2008163044A (ja) | 2008-07-17 |
WO2003048192A1 (fr) | 2003-06-12 |
US8183343B2 (en) | 2012-05-22 |
CN1599748A (zh) | 2005-03-23 |
EP1462455A1 (en) | 2004-09-29 |
SI1462455T1 (sl) | 2013-09-30 |
AU2002354188A1 (en) | 2003-06-17 |
KR20100002291A (ko) | 2010-01-06 |
EP1462455B1 (en) | 2013-04-10 |
US20090005317A1 (en) | 2009-01-01 |
JP4310588B2 (ja) | 2009-08-12 |
US7232881B2 (en) | 2007-06-19 |
US7795222B2 (en) | 2010-09-14 |
KR20050044630A (ko) | 2005-05-12 |
TW200302108A (en) | 2003-08-01 |
PT1462455E (pt) | 2013-07-09 |
EP2172474B1 (en) | 2013-04-17 |
CY1114330T1 (el) | 2016-08-31 |
KR100993233B1 (ko) | 2010-11-10 |
EP2172474A1 (en) | 2010-04-07 |
CN1263770C (zh) | 2006-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7795222B2 (en) | Methods for treating a corneal disorder and promoting skin wound healing | |
JP5701375B2 (ja) | 血管新生促進用ペプチド及びその使用 | |
CA2418976C (en) | Skin wound healing promoters | |
ES2268730T3 (es) | Composiciones farmacologicas oftalmicas. | |
JP4253743B2 (ja) | 新規ペプチドおよびその医薬用途 | |
JP4096115B2 (ja) | 皮膚創傷治癒促進剤 | |
CA2106858A1 (en) | Small peptidic compounds useful for the treatment of glaucoma | |
JP5752782B2 (ja) | 血管新生促進用ペプチド及びその使用 | |
CA2423190C (fr) | Agent angiogeniques et leurs utilisations | |
JP4313033B2 (ja) | 眼科用治療組成物 | |
ES2348471T3 (es) | Promotores de cicatrización de heridas. | |
JP2006117556A (ja) | アミノ酸配列がSer−Ser−Ser−Argで表されるペプチドの医薬用途 | |
CA2106860A1 (en) | Organosulphur compounds useful for the treatment of glaucoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130531 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140603 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150515 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160517 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170522 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180529 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190530 Year of fee payment: 10 |